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Genetic Therapy Reverses Nervous System Damage
By Greg Lester

By injecting a therapeutic gene directly into
the brain, researchers have treated a naturally
occurring genetic disease in cats. This is the ﬁrst
genetic disease affecting the central nervous
system to be successfully treated in an animal
larger than mice and rats. If this approach
can be applied successfully to humans, say the
researchers, it might one day treat an entire class
of diseases called lysosomal storage disorders,
which cause severe, sometimes fatal, disabilities
in about one in 5,000 births. The members
of the research team from the University of
Pennsylvania School of Veterinary Medicine, the
Children’s Hospital of Philadelphia, and the U.S.
Naval Academy published their ﬁndings in the
March 2005 Annals of Neurology.
The animals involved in the study are born
with a genetic disorder directly analogous to
alpha-mannosidosis, or AMD, an inherited
disease in humans that causes severe mental
retardation and skeletal abnormalities. Cats
with AMD do not live more than six months.
Children born with the worst form of the disease
rarely survive into their teens.
“Through gene therapy, we replace a ‘broken’
gene responsible for alpha-mannosidase with the
correct, functioning copy, to dramatic results,”
said John H. Wolfe, professor of pathology and
medical genetics at the School of Veterinary
Medicine and a neurology researcher at Children’s Hospital. “The treated cats were markedly
improved compared to diseased cats, with better
balance and muscle control and fewer tremors.”
Although the disease itself is rare, AMD is
one of about 50 lysosomal storage diseases, a
class of diseases that accounts for a signiﬁcant
portion of the instances of mental retardation
in children. Other examples include Tay-Sachs
disease, Hunter disease, and Pompe disease. In a
lysosomal storage disease, cellular debris accumulates within storage areas of cells called lysosomes.
In the case of AMD, children are born with a
faulty version of the gene for an enzyme called
lysosomal alpha-mannosidase, or LAMAN.
“Shortly after birth, brain tissue is still
physically maturing, which means that there is a
particularly important window of opportunity
for gene therapy in infants,” Dr. Wolfe said. “In
our study, we could see that gene therapy used
during this particular time led to a restoration of
damaged neurons, even though the lesions that
represent the disease were already extensive.”

According to Charles H. Vite, lead author of
the paper and assistant professor of veterinary
neurology at Penn, the treated cats not only
demonstrated dramatic clinical improvement,
but MRI also revealed that white matter tracks,
myelin, in the brain had been largely restored.
“As we move toward the clinical use of this
therapy in humans, we must develop and utilize
noninvasive methods to monitor the regression
of the disease following treatment,” Dr. Vite said.
“The ability to monitor the improvement in brain
myelination in alpha-mannosidosis using imaging
allows the clinician to see improvement in brain
pathology without the need for brain biopsy.”
The large-animal study also demonstrated
that only a limited number of injections are
necessary to introduce the working LAMAN
gene, one of the ﬁrst steps that will prepare
this particular gene therapy for practical use in
humans. The gene is transported via a neutralized virus that “infects” cells with the functioning
gene. Since the blood-brain barrier would block
the virus carrying the gene if it were circulating
in the bloodstream, the researchers injected the
virus directly into the brain.

“The brain of the cat is much closer in size
to the human infant brain compared to mice.
Thus we think that it may be possible to achieve
similar results in humans with as few as 20 to 30
injections in each of the two hemispheres of the
brain,” Dr. Wolfe said. “We believe, however, we
can further limit the number of injections by the
use of strong promoters that could increase the
amount of enzyme that comes from corrected
cells.”
Although encouraged by their ﬁndings,
the researchers note that any clinical trials in
humans might be years in the future.
Video comparing a cat with AMD to one that
had been given gene therapy is available at
www.mrw.interscience.wiley.com/suppmat/
0364-5134/suppmat/2005/57/v57.3.355.html.
Funding for this research was provided by the
National Institutes of Health. In addition to Drs.
Wolfe and Vite, researchers involved in the study
include Joseph G. McGowan; Sumit N. Niogi;
Marco A. Passini; Kenneth J. Drobatz, associate
professor of critical care at the Ryan Hospital;
and Mark E. Haskins, V’69, professor of pathology and medical genetics. ■

Walter Goodman and Skye Terriers:
“Love at First Sight”
In 1936, 14-year-old Walter Flato Goodman
was vacationing with his family in Paris when he
saw his ﬁrst Skye terrier, and it was love at ﬁrst
sight. When the Goodmans returned to America,
a Skye puppy was in tow. Thus Walter’s future as
a one of the world’s most prominent breederowner-handlers of Skyes was born.
Since that day, Walter and his terriers have
won 99 Best in Show awards and 300 Terrier
Group First awards. He is a member of the
Westbury Kennel Association, the Westminster
Kennel Club, the Palm Beach County Dog
Fanciers Association, and The Kennel Club (of
England). Walter is President and Chief Steward
of the Montgomery County Kennel Club in
Pennsylvania, which holds the world’s largest
annual terrier show. As the Delegate of the Skye
Terrier Club of America, he is a member of the
Board of Directors of the American Kennel Club.
Since 1975, Walter has been approved to judge
Best in Show, the Terrier Group, and Junior
Showmanship competitions.
Walter has long supported the School; he
joined its Board of Overseers in 1986, and, with

his associate, Robert A. Flanders, established
two irrevocable trusts at Penn. In fall 2003, the
School honored Walter by naming its research
center the Walter Flato Goodman Center for
Comparative Medicine and Genetics, dedicated
to clinical and basic research for companion
animals with diseases that parallel those in
humans. ■

Walter Goodman (left) with his Skye terrier “Evie,” who was
judged Best in the Terrier Group by Jeremiah O’Callaghan at
the 1957 show of the Kennel Club of Philadelphia.

BELLWETHER 62

9

